Dysglycemia and a history of reproductive risk factors

Diabetes Care. 2008 Aug;31(8):1635-8. doi: 10.2337/dc08-0621. Epub 2008 May 5.

Abstract

Objective: The purpose of this study was to identify reproductive risk factors associated with dysglycemia (diabetes, impaired glucose tolerance, and impaired fasting glucose) in a contemporary multiethnic population.

Research design and methods: We studied 14,661 women screened with an oral glucose tolerance test for the Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication (DREAM) trial. Reproductive risk factors were compared in normoglycemic and dysglycemic women.

Results: Dysglycemia was significantly associated with the number of children born (odds ratio 1.03 per child [95% CI 1.01-1.05]), age (1.05 per year [1.04-1.05]), non-European ancestry (1.09 [1.01-1.17]), preeclampsia/eclampsia (1.14 [1.02-1.27]), irregular periods (1.21 [1.07-1.36]), and gestational diabetes mellitus (GDM) (1.53 [1.35-1.74]). The relationship between GDM and dysglycemia did not differ across BMI tertiles (P = 0.84) nor did the relationships of other risk factors.

Conclusions: Reproductive factors, particularly GDM, are associated with dysglycemia in middle-aged women from many ethnicities. Reproductive factors can be used to counsel young women about their future risk of dysglycemia, whereas in middle age they may help screen for dysglycemia.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Blood Glucose / metabolism*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes, Gestational / epidemiology*
  • Diabetes, Gestational / prevention & control
  • Female
  • Glucose Intolerance / blood*
  • Glucose Intolerance / drug therapy
  • Glucose Tolerance Test
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Middle Aged
  • Ontario / epidemiology
  • Parity
  • Poverty
  • Pregnancy
  • Pregnancy Complications / epidemiology*
  • Pregnancy Complications / prevention & control
  • Ramipril / therapeutic use
  • Risk Factors
  • Rosiglitazone
  • Thiazolidinediones / therapeutic use

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Blood Glucose
  • Hypoglycemic Agents
  • Thiazolidinediones
  • Rosiglitazone
  • Ramipril